Ibotta, Inc.
NYSE:IBTASoftware - Application
-$0.19 today
- Market cap
- $1.16B
- Beta
- -0.58
- P/E (TTM)
- -96.1
- EPS (TTM)
- -$0.30
Volume 0.45M
Average 0.22M
IBTA EBITDA Margin
EBITDA as a percentage of revenue.
Ibotta, Inc.NYSE: IBTA
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin narrows to -7.9%
EBITDA Margin was -7.9% in Q1 FY2026, down 11.0 pp from a year earlier. On a trailing-twelve-month basis it was 2.2%, down 2.8 pp year over year. Over 3 fiscal years it widened by 25.7 pp.
Context
- EBITDA Margin widened in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 6 analysts of -2.3% for the fiscal year ending Dec 2026, down from 5.3% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -7.9%-10.9 pp QoQ
- Last fiscal yearDec 2025
- 5.3%-3.6 pp YoY
- LTMMar 2026
- 2.2%-2.8 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -11.0 pp | -7.5 pp | +3.5 pp |
| 1 year | -3.6 pp | -7.6 pp | -4.0 pp |
| 3 years | +25.7 pp | -1.3 pp | -27.0 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 5.3%
- Year-over-year change
- -3.6pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.3% | -3.6pp |
| FY2024 | 2024-12-31 | 8.9% | -9.1pp |
| FY2023 | 2023-12-31 | 18.0% | +38.4pp |
| FY2022 | 2022-12-31 | -20.4% | — |
EBITDA Margin vs competitors
How IBTA compares with its peers on the latest reported figures
- IBTA's LTM Mar 2026 EBITDA Margin of 2.2% is the 9th highest of the 10 companies compared; the peer median is 11.6%.
- Its year-over-year change of -2.8 pp is the 8th highest of 10, against a peer median of +2.0 pp.
- Over three fiscal years its change of +25.7 pp compares with a peer median of +14.1 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 37.6% | +4.7 pp | +35.1 pp | |
| LTM Mar 2026 | 28.6% | -32.7 pp | -20.4 pp | |
| LTM Mar 2026 | 25.7% | -1.1 pp | +14.1 pp | |
| LTM Mar 2026 | 11.9% | -37.7 pp | -2.0 pp | |
| LTM Mar 2026 | 11.6% | +2.0 pp | +43.1 pp | |
| LTM Mar 2026 | 10.1% | -1.1 pp | +4.1 pp | |
| LTM Mar 2026 | 9.3% | +3.4 pp | -8.4 pp | |
| LTM Mar 2026 | 3.5% | +19.7 pp | +311.4 pp | |
| LTM Mar 2026 | 2.2% | -2.8 pp | +25.7 pp | |
| LTM Mar 2026 | -1.0% | +10.1 pp | +34.8 pp | |
| Peer median (excluding IBTA) | 11.6% | +2.0 pp | +14.1 pp | |
Competitors are the stored peer set for IBTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 210.7M | 320.04M | 367.25M | 342.39M |
| Cost of Revenue | 49.22M | 47.65M | 50.12M | 74.97M |
| Gross Profit | 161.48M | 272.38M | 317.13M | 267.42M |
| Gross Margin | 76.6% | 85.1% | 86.4% | 78.1% |
| Research & Development | 42.56M | 50M | 63.27M | 61.08M |
| Selling, General & Admin | 159.23M | 166.39M | 221.95M | 207.18M |
| Operating Expenses | 201.79M | 216.39M | 289.21M | 265.77M |
| Depreciation & Amortization | 6.32M | 6.66M | 8.08M | 8.32M |
| EBITDA | (42.97M) | 57.6M | 32.58M | 18.17M |
| EBITDA Margin | -20.4% | 18.0% | 8.9% | 5.3% |
| Operating Income | (40.31M) | 56M | 27.93M | 1.66M |
| Operating Margin | -19.1% | 17.5% | 7.6% | 0.5% |
| Interest Income | 0 | 0 | 9.41M | 10.78M |
| Interest Expense | 5.31M | 6.88M | 0 | 0 |
| Other Income / Expenses | (14.29M) | (11.95M) | (3.43M) | 8.19M |
| Income Before Tax | (54.6M) | 44.05M | 24.5M | 9.85M |
| Pre-Tax Margin | -25.9% | 13.8% | 6.7% | 2.9% |
| Income Tax Expense | 262K | 5.93M | (44.25M) | 6.27M |
| Net Income | (54.86M) | 38.12M | 68.74M | 3.58M |
| Net Margin | -26.0% | 11.9% | 18.7% | 1.0% |
| EPS (Basic) | (1.81) | 1.26 | 2.85 | 0.13 |
| EPS (Diluted) | (1.81) | 1.26 | 2.56 | 0.12 |
| Weighted Avg Shares | 30.24M | 30.24M | 24.12M | 28.37M |
| Weighted Avg Shares (Diluted) | 30.24M | 30.24M | 26.86M | 30.1M |
Ibotta, Inc.
NYSE:IBTA
Intrinsic Alpha fair value
Locked
Current Price
$56.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.